Our new report Orthobiologics: Global Market Prospects 2012-2022 covers the
trends in the orthobiologics market, a promising segment of the orthopaedic
sector. The orthobiologics market will see significant growth during the
period 2012-2022. Growth will be driven primarily by the increasing prevalence
of arthritic conditions such as, osteoarthritis and osteoporosis. In addition,
an increase in demand for minimally invasive products that offer improved
comfort and durability will further drive growth of this market. Technological
advancements in the field of orthobiologics have seen innovations such as
liquid allografts and bone glues that not only repair fractured bone but also
provide mechanical support for the healing process. This trend in
technological advancements will continue during the forecast period and will
also be a key factor that will sustain growth of the orthobiologics market.
According to our latest pharma report - the global orthobiologics market will
be worth $8.4bn by 2016.
The largest sector in orthobiologics in 2010 was bone grafts, accounting for
41.6% of the global market. Market growth in this sector is driven by the
demand to develop bone graft substitutes as an alternative to using autograft
bone, which has reported to have been associated with a number of
complications such as, immunogenic rejection, infection, nerve injury and
bleeding. There is also a limited supply of this type of bone graft. For these
reasons, patient demand will be driven by the search for adequate alternatives
such as allografts and synthetic bone grafts. This will fuel growth in the
demand of these products, strengthening the marketing position of the bone
grafts sector during the forecast period.
Orthobiologics: Global Market Prospects 2012-2022 also examines the size and
value of leading national/regional markets. For each of these, visiongain
identifies prevailing trends and strategies that will steer this emerging
technology over the forecast period. The report also analyses the challenges
facing the sector critically, including the safety issues. The report is
developed through a comprehensive review of information sources, both primary
and secondary. In our report you find sales forecasts, growth rates and market
shares. You also receive qualitative analyses and a review of companies and
leading products.
Why you should buy Orthobiologics: Global Market Prospects 2012-2022
In this report, you will receive the following benefits in particular:
You will receive our assessment of the market for orthobiologics in 2010,
with respect to the leading segments, products, companies and national markets
You will discover sales trends for the overall orthobiologics market from
2011 to 2022 - seeing where commercial growth will occur
You will discover sales trends for the main segments - bone grafts, growth
factors and stem cells - from 2011 to 2022, with detailed discussions of
market potential
You will receive sales forecasts for leading national/regional markets
(US, Japan, Europe, India and China), with informed discussion
You will assess leading manufacturers and products in the leading segments
of the orthobiologics market, with information on the pipeline products
You will examine the strengths, weaknesses, opportunities and threats
(SWOT analysis) facing the infusion pumps market from 2012 onwards
You will be able to investigate competition and opportunities influencing
the orthobiologics market from 2012 onwards
You will see what will stimulate and restrain the market from 2012
You will discover the unmet needs in the market, driving the growth from
2012 onwards
You will view expert opinion from our survey.
Table of Contents
Table of Contents
1. Executive Summary
1.1 Sector Highlights
1.2 Aims, Scope and Format of the Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Related to Report
2. Introduction to Orthobiologics
2.1 Orthobiology
2.2 Types of Orthobiologics
2.3 Bone Grafts
2.3.1 Autograft
2.3.2 Allograft
2.3.3 Other Types of Bone Grafts
2.4 Growth Factors (GFs)
2.4.1 GF Proteins
2.4.2 Bone Morphogenetic Proteins (BMPs)
2.5 Stem Cells
2.6 The Potential of Orthobiologics
3. The Orthobiologics Market, 2010-2022
3.1 The Global Medical Devices Market, 2010
3.2 The Global Orthopaedic Devices Market, 2010
3.2.1 Orthopaedic Devices Market Trends, 2010
3.3 The Global Orthobiologics Market, 2010
3.4 Orthobiologics Market Forecast, 2011-2022
3.5 Orthobiologics Market Trends, 2012-2022
3.5.1 Increasing Use of Bone Graft Materials
3.5.2 Patient Demographics
3.5.3 Huge Potential for Growth Factors and Stem Cell Therapy
4. The Bone Grafts Market, 2010-2022
4.1 Bone Grafting
4.1.1 Bone Tissue
4.1.2 Biological Mechanism of Bone Grafting
4.2 Bone Grafts Market, 2010
4.3 Bone Grafts Market Forecast, 2011-2022
4.4 Bone Grafts Market Trends, 2012-2022
4.4.1 Spinal Fusion Procedures to Drive Bone Graft Usage
4.4.2 Increasing Demand for Bone Graft Substitutes
5. The Growth Factors Market, 2010-2022
5.1 Growth Factors
5.1.1 Wound Healing and The Role of Growth Factors
5.2 Bone Morphogenetic Proteins (BMP)
5.3 The BMP Market in 2010: Products and Companies
5.4 Growth Factors Market Forecast, 2011-2022
5.5 Growth Factors Market Trends, 2012-2022
5.5.1 Use in Spinal Fusion Procedures
5.5.2 Increasing Preference for BMPs
6. The Stem Cells Market, 2010-2022
6.1 Stem Cells
6.2 Stem Cell Therapy for Orthopaedics, 2010
6.3 Stem Cells Market Forecast, 2011-2022
6.4 Stem Cells Market Trends, 2012-2022
7. Leading Companies in The Orthobiologics Market, 2010
7.1 Intensively Competitive Market
7.2 Leading Companies in the Orthobiologics Market, 2010
7.3 Medtronic
7.3.1 Sales and Recent Performance Analysis, 2010
7.3.1.1 Spinal Sector
7.3.2 Medtronic's Orthobiologic Products
7.3.3 Acquisition of Otseotech
7.4 Genzyme
7.4.1 Sales and Recent Performance Analysis, 2010
7.4.2 Genzyme's Orthobiologic Products
7.4.3 Genzyme Enter Huge Japanese Market
7.5 Stryker
7.5.1 Sales and Recent Performance Analysis, 2010
7.5.2 Financial Analysis By Sector
7.5.2.1 Medical And Surgical
7.5.2.2 Orthopaedic Implants
7.5.3 Stryker's Orthobiologic Products
7.5.3.1 Allografts
7.5.3.2 Synthetics
7.5.4 Orthovita Inc. Acquisition To Strengthen Orthobiologic Portfolio
7.6 Integra Life Sciences
7.6.1 Sales and Recent Performance Analysis, 2010
7.6.2 Integra Life Sciences' Orthobiologic Products
7.6.3 New Product to Strengthen Advanced Orthobiologics Portfolio
7.7 Wright Medical
7.7.1 Sales and Recent Performance Analysis, 2010
7.7.2 Wright Medical's Orthobiologic Products
7.7.3 Cost Restructuring Plan Aims to Foster Future Growth
7.8 AAP Implantate
7.8.1 Sales and Recent Performance Analysis, 2010
7.8.2 AAP Implantate's Orthobiologic Products
7.9 Other Companies
7.10 Zimmer
7.10.1 Sales and Recent Performance Analysis, 2010
7.10.2 Zimmer's Orthobiologic Products
7.10.3 Asia-Pacific Expansion
8. Leading National Orthobiologic Markets, 2010
8.1 Regional Breakdown of The Global Orthobiologics Market, 2010
8.2 The Global Orthobiologics Market: Regional Forecast, 2011-2022
8.3 The US Market
8.4 The European Market
8.4.1 Germany and France
8.4.2 Italy
8.4.3 Spain
8.4.4 U.K
8.5 The Japanese Market
8.6 The Indian Market
8.7 The Chinese Market
9. SWOT Analysis of the Orthobiologics Market, 2012
9.1 Orthobiologics: Industry Trends
9.2 Strengths
9.2.1 Patient Demographics
9.2.2 Less Invasive and Safer
9.3 Weaknesses
9.3.1 Risks
9.3.2 Lack of Comparative Efficacy
9.4 Opportunities
9.4.1 Continued Investment
9.4.2 Globalisation
9.5 Threats
9.5.1 Regulatory Approval Process
9.5.2 Medical Device Excise Tax
10. Orthobiologics: Product Pipeline, 2010
10.1 Innovative Technology Drives the Market
10.2 Bone Glue
10.3 Liquid Allograft
10.4 Gene Activated Matrix Technology
11. Expert Opinion
11.1 Interview with ISTO Technologies, Inc.
11.1.1 The Orthobiologics Market
11.1.2 Orthobiologics Role in Relation to Other Treatment Options
11.1.3 Public/Patient Awareness
11.1.4 ISTO Technologies: Products And Platforms
11.1.5 Challenges Facing ISTO Technologies
11.1.6 Competition In The Orthobiologics Industry
11.1.7 Future Projections
12. Conclusions
12.1 Overview
12.2 Bone Grafts Will Remain the Largest Segment
12.3 Prominent Companies in the Market
12.4 World Market Forecasts
12.5 Future Outlook and Concluding Remarks
Appendix A
Appendix B: Visiongain report evaluation form
List of Tables
Table 2.1 Other Types of Bone Graft Procedures, 2010
Table 3.1 The Medical Device Market: Global Sales ($bn) by Sector, 2010
Table 3.2 Orthopaedic Devices Market: Global Sales ($bn) and Market Shares
(%) by Sector, 2010
Table 3.3 Orthobiologics Market: Net Sales ($bn) and Market Shares (%) by
Sector, 2010
Table 3.4 Orthobiologics Market Forecast ($bn) by Segment, 2010-2016
Table 3.5 Orthobiologics Market Forecast ($bn) by Segment, 2016-2022
Table 4.1 Mechanisms Involved in Bone Grafting
Table 4.2 Bone Grafts: Net Sales ($bn) by Type of Graft, 2010
Table 4.3 Bone Grafts: Market Forecast ($bn), 2010-2022
Table 5.1 Types and Characteristics of Main BMPs, 2010
Table 5.2 Growth Factors Market: Net Sales ($bn) by Type of Growth Factor,
2010
Table 5.3 Leading Products in the BMP Market, 2010
Figure 8.3 The US Orthobiologics Market Forecast ($bn), 2010-2022
Figure 8.4 The European Orthobiologics Market: Sales ($bn) by Leading
Countries, 2010
Figure 8.5 The European Orthobiologics: Market Shares (%) by Leading
Countries, 2010
Figure 8.6 The European Orthobiologics Market Forecast ($bn), 2010-2022
Figure 8.7 The German and French Orthobiologics Market Forecasts ($bn),
2010-2022
Figure 8.8 The Italian Orthobiologics Market Forecast ($bn), 2010-2022
Figure 8.9 The Spanish Orthobiologics Market Forecast ($bn), 2010-2022
Figure 8.10 The UK Orthobiologics Market Forecast ($bn), 2010-2022
Figure 8.11 The Japanese Orthobiologics Market Forecast ($bn), 2010-2022
Figure 8.12 The Indian Orthobiologics Market Forecast ($bn), 2010-2022
Figure 8.13 The Chinese Orthobiologics Market Forecast ($bn), 2010-2022
Figure 12.1 Projected Total Orthobiologics Market Size ($bn) in 2010,
2016, 2018 and 2022
Figure 12.2 Projected Market Size ($bn): Bone Grafts, Growth Factors and
Stem Cells Market in 2010, 2016, 2018 and 2022
Companies Listed
AAP Implantate
Aastrom Biosciences Inc.
Allograft Tissue systems
AlloSource
Alphatech Spine
American Association of Tissue Banks (AATB)
Anika Therapeutics Inc
Arteriocyte Medical Systems Inc
Artimplant AB
B Braun Melsungen AG
Bacterin International
Baxter International Inc
Berkeley Advanced Biomaterials Inc.
Biocomposites Ltd
Biocoral Inc
Biologic Therapies
Biomatlante
Biomet Inc.
BioMimetic Therapeutics
Bioset Inc.
BioTissue AG
Bone Solutions Inc
BoneSupport AB
Cardium Therapeutics
Ceramisys Ltd
Cerapedics Inc
co.don AG
Collagen Matrix Inc
curasan AG
Cytomedix Inc
DePuy Inc.
ETEX Corporation
Exactech Inc.
Food and Drug Administration (FDA)
Geistlich Pharma AG
Genzyme
Graftys
Harvest Technologies
Histogenics Corp
Integra LifeSciences
ISTO Technologies Inc
Kasios
Kensey Nash Corp
Kinetic Concepts Inc
Kuros Biosurgery AG
Lanx Inc
Lindare Medical
Medtronic
Mesoblast Ltd
MiMedx Group Inc.
North American Spine Society
NovaBone Products LLC
NuVasive Inc
Olympus Terumo
Orteq Bioengineering
Orthofix International NV
Orthovita
Osiris Therapeutics Inc
Osteotech
Pioneer Surgical Technology
PolyNovo Biomaterials Ltd
RTI Biologics Inc
Skye Orthobiologics
Smith & Nephew
Stryker Corporation
Synovis Life Technologies
Synthes
Teijin Pharma
TEKNIMED SA
Tigenix
Tissue Banks International
Tissue Genesis Inc
TissueGene Inc
Tornier
Wright Medical
Zimmer
Orthobiologics: Global Market Prospects 2012-2022 published by Visiongain in March 7, 2012. This report consists of 123 Pages and the price starts from US $ 2739.
